Related Experiment Video

Updated: May 3, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

10.1K

Taming endothelial activation with a microRNA

Jason E Fish1, Myron I Cybulsky

  • 1Division of Cellular and Molecular Biology, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada. jason.fish@utoronto.ca

The Journal of Clinical Investigation
|May 25, 2012
PubMed

Insights

MicroRNA-181b (miR-181b) controls inflammation in blood vessels by regulating NF-κB. Targeting miR-181b offers a potential therapy for vascular diseases like sepsis and atherosclerosis.

Area of Science:

  • Vascular biology
  • Molecular medicine
  • Immunology

Background:

  • Inflammation is central to vascular diseases such as sepsis and atherosclerosis.
  • Discovering negative regulators of inflammatory pathways is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the role of microRNA-181b (miR-181b) in regulating inflammatory signaling in endothelial cells.
  • To identify miR-181b as a potential therapeutic target for inflammatory vascular conditions.

Main Methods:

  • The study examined the function of miR-181b in endothelial cells.
  • NF-κB signaling pathway regulation was analyzed.
  • The interaction between miR-181b and importin-α3 was investigated.

Main Results:

  • MicroRNA-181b (miR-181b) was found to be a key regulator of inflammation in endothelial cells.
  • miR-181b targets importin-α3, a protein involved in NF-κB nuclear import.
  • This mechanism effectively controls inflammatory responses.

Conclusions:

  • Modulating microRNAs, specifically miR-181b, presents a promising therapeutic strategy.
  • Targeting miR-181b could offer a novel approach for treating inflammatory vascular diseases.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K